These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Imaging in Parkinson's Disease. Politis M; Pagano G; Niccolini F Int Rev Neurobiol; 2017; 132():233-274. PubMed ID: 28554409 [TBL] [Abstract][Full Text] [Related]
9. Relationship between cerebrospinal fluid biomarkers and structural brain network properties in Parkinson's disease. Abbasi N; Mohajer B; Abbasi S; Hasanabadi P; Abdolalizadeh A; Rajimehr R Mov Disord; 2018 Mar; 33(3):431-439. PubMed ID: 29436735 [TBL] [Abstract][Full Text] [Related]
10. Neuroimaging in Parkinson's disease. Brooks DJ NeuroRx; 2004 Apr; 1(2):243-54. PubMed ID: 15717025 [TBL] [Abstract][Full Text] [Related]
11. Use of Magnetic Resonance Imaging and Artificial Intelligence in Studies of Diagnosis of Parkinson's Disease. Xu J; Zhang M ACS Chem Neurosci; 2019 Jun; 10(6):2658-2667. PubMed ID: 31083923 [TBL] [Abstract][Full Text] [Related]
13. Imaging the Functional Neuroanatomy of Parkinson's Disease: Clinical Applications and Future Directions. Lauretani F; Longobucco Y; Ravazzoni G; Gallini E; Salvi M; Maggio M Int J Environ Res Public Health; 2021 Feb; 18(5):. PubMed ID: 33670940 [TBL] [Abstract][Full Text] [Related]
14. α-synuclein imaging: a critical need for Parkinson's disease research. Eberling JL; Dave KD; Frasier MA J Parkinsons Dis; 2013; 3(4):565-7. PubMed ID: 24192754 [TBL] [Abstract][Full Text] [Related]
15. The role of magnetic resonance imaging in the diagnosis of Parkinson's disease: a review. Al-Radaideh AM; Rababah EM Clin Imaging; 2016; 40(5):987-96. PubMed ID: 27288741 [TBL] [Abstract][Full Text] [Related]
16. Current status and future challenges of brain imaging with (18)F-DOPA PET for movement disorders. Calabria FF; Calabria E; Gangemi V; Cascini GL Hell J Nucl Med; 2016; 19(1):33-41. PubMed ID: 26929938 [TBL] [Abstract][Full Text] [Related]
17. The role of biomarkers and imaging in Parkinson's disease. Algarni MA; Stoessl AJ Expert Rev Neurother; 2016; 16(2):187-203. PubMed ID: 26829357 [TBL] [Abstract][Full Text] [Related]
19. Brain PET imaging of phosphodiesterase 10A in progressive supranuclear palsy and Parkinson's disease. Koole M; Van Laere K; Ahmad R; Ceccarini J; Bormans G; Vandenberghe W Mov Disord; 2017 Jun; 32(6):943-945. PubMed ID: 28394032 [No Abstract] [Full Text] [Related]